Two of Roches oncology blockbusters are facing dire straits as first-ever biosimilar competitors have entered the U.S. market. Now, a major insurer is putting its money on the new guys.
Chemical Name |
Synonyms |
Molecular Formula |
Molecular Weight |
---|
Product Name | Innovator |
---|
Product Name | Market Status |
---|
Product Name | Indication |
---|
Product Name | Therapeutic Segment |
---|
Your product will be updated soon in our database